Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trial

AR Parikh, A Szabolcs, JN Allen, JW Clark, JY Wo… - Nature cancer, 2021 - nature.com
Overcoming intrinsic resistance to immune checkpoint blockade for microsatellite stable
(MSS) colorectal cancer (CRC) and pancreatic ductal adenocarcinoma (PDAC) remains …
被引用次数：146 相关文章

Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trial.

AR Parikh, A Szabolcs, JN Allen, JW Clark, JY Wo… - Nature Cancer, 2021 - europepmc.org
Overcoming intrinsic resistance to immune checkpoint blockade for microsatellite stable
(MSS) colorectal (CRC) and pancreatic (PDAC) cancer remains challenging. We conducted …

Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trial

AR Parikh, A Szabolcs, JN Allen, JW Clark… - Nature …, 2021 - pubmed.ncbi.nlm.nih.gov
Overcoming intrinsic resistance to immune checkpoint blockade for microsatellite stable
(MSS) colorectal cancer (CRC) and pancreatic ductal adenocarcinoma (PDAC) remains …
[HTML] nih.gov

[HTML][HTML] Radiation Therapy Enhances Immunotherapy Response in Microsatellite-stable Colorectal and Pancreatic Adenocarcinoma in a Phase II Trial

AR Parikh, A Szabolcs, JN Allen, JW Clark, JY Wo… - Nature …, 2021 - ncbi.nlm.nih.gov
Radiation Therapy Enhances Immunotherapy Response in Microsatellite-stable Colorectal and
Pancreatic Adenocarcinoma in a Phase II Trial - PMC Back to Top Skip to main content NIH …